Argent Biopharma (AU:RGT) has released an update.
Argent BioPharma Limited has requested an immediate trading halt on the ASX, pending an announcement about a forthcoming capital raising initiative. The halt will remain in effect until either the company’s announcement is made public or trading resumes on Tuesday, 16 July 2024. The company has declared there are no known reasons why the halt should not be granted and has not disclosed further details to the market at this time.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
